New Oxford study suggests millions of people may have already built up coronavirus immunity

A model predicting the progression of the novel coronavirus pandemic produced by researchers at Imperial College London set off alarms across the world and was a major factor in several governments' decisions to lock things down. But a new model from Oxford University is challenging its accuracy, the Financial Times reports.
The Oxford research suggests the pandemic is in a later stage than previously thought and estimates the virus has already infected at least millions of people worldwide. In the United Kingdom, which the study focuses on, half the population would have already been infected. If accurate, that would mean transmission began around mid-January and the vast majority of cases presented mild or no symptoms.
The head of the study, professor Sunetra Gupta, an Oxford theoretical epidemiologist, said she still supports the U.K.'s decision to shut down the country to suppress the virus even if her research winds up being proven correct. But she also doesn't appear to be a big fan of the work done by the Imperial College team. "I am surprised that there has been such unqualified acceptance of the Imperial model," she said.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
If her work is accurate, that would likely mean a large swath of the population has built up resistance to the virus. Theoretically, then, social restrictions could ease sooner than anticipated. What needs to be done now, Gupta said, is a whole lot of antibody testing to figure out who may have contracted the virus. Her research team is working with groups from the University of Cambridge and the University of Kent to start those tests for the general population as quickly as possible. Read more at the Financial Times.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Today's political cartoons - February 19, 2025
Cartoons Wednesday's cartoons - marking territory, living under a rock, and more
By The Week US Published
-
Mickey 17: 'charming space oddity' that's a 'sparky one-off'
The Week Recommends 'Remarkable' Robert Pattinson stars in Bong Joon-ho's sci-fi comedy
By Irenie Forshaw, The Week UK Published
-
EastEnders at 40: are soaps still relevant?
Talking Point Albert Square's residents are celebrating, but falling viewer figures have fans worried the soap bubble has burst
By Elizabeth Carr-Ellis, The Week UK Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published